FP7H2020HORIZON
European Organisation for Research and Treatment of Cancer Aisbl
- Country
- BEBelgium
- Defence projects
- 0
- Projects, all programmes
- 30
- As coordinator
- 6
- EU contribution (CORDIS)
- EUR 22,974,449
- Active
- 2008 to 2023
Projects
30 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| EUonQoLQuality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe | HORIZON | 2023 | Participant | EUR 583,000 |
| CCI4EUCOMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE | HORIZON | 2023 | Participant | EUR 110,500 |
| DE-ESCALATEINTERMITTENT ANDROGEN DEPRIVATION THERAPY IN THE ERA OF ANDROGEN RECEPTOR PATHWAY INHIBITORS; A PHASE 3 PRAGMATIC RANDOMISED TRIAL | HORIZON | 2023 | Coordinator | EUR 6,266,913 |
| LEGATOLomustine with or without reirradiation for first progression of glioblastoma: a pragmatic randomized phase III study | HORIZON | 2023 | Coordinator | EUR 4,492,234 |
| STREXIT2A PRAGMATIC CLINICAL STUDY OF NEOADJUVANT CHEMOTHERAPY FOLLOWED BY SURGERY VERSUS SURGERY ALONE FOR PATIENTS WITH HIGH RISK RETROPERITONEAL SARCOMA | HORIZON | 2023 | Coordinator | EUR 4,113,125 |
| canSERVProviding cutting edge cancer research services across Europe | HORIZON | 2022 | Participant | EUR 638,895 |
| STRONG-AYATHE STRONG-AYA INITIATIVE: IMPROVING THE FUTURE OF YOUNG ADULTS WITH CANCER | HORIZON | 2022 | Participant | EUR 400,300 |
| OPTIMAOptimal treatment for patients with solid tumours in Europe through Artificial intelligence | H2020 | 2021 | Participant | EUR 75,001 |
| SISAQOL-IMIEstablishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials | H2020 | 2021 | Coordinator | Not stated |
| HTxNext Generation Health Technology Assessment to support patient-centred, societally oriented, real-time decision-making on access and reimbursement for health technologies throughout Europe | H2020 | 2019 | Participant | EUR 862,250 |
| EJP RDEuropean Joint Programme on Rare Diseases | H2020 | 2019 | Participant | EUR 5,150 |
| PIONEERProstate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope | H2020 | 2018 | Participant | EUR 16,000 |
| HARMONYHealthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 | H2020 | 2017 | Participant | EUR 30,203 |
| IB4SD-TRISTANImaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 | H2020 | 2017 | Coordinator | EUR 414,480 |
| MoTriColorMolecularly guided trials with specific treatment strategies in patients with advanced newly molecular defined subtypes of colorectal cancer (MoTriColor) | H2020 | 2015 | Participant | EUR 331,000 |
| CANCER-IDCancer treatment and monitoring through identification of circulating tumour cells and tumour related nucleic acids in blood | FP7 | 2015 | Participant | EUR 140,000 |
| GETREALIncorporating real-life clinical data into drug development | FP7 | 2013 | Participant | EUR 269,500 |
| HERMIONE-2MANFirst in Man Novel Anticancer Therapeutic based on Dependence Receptors Concept | FP7 | 2013 | Participant | EUR 507,562 |
| EECEURO EWING Consortium – International Clinical Trials to Improve Survival from Ewing Sarcoma | FP7 | 2013 | Participant | EUR 648,804 |
| EUPATIEuropean Patients' Academy on Therapeutic Innovation | FP7 | 2012 | Participant | EUR 56,245 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.